May 28, 2020

On May 27, VDP temporarily revised the preferred drug list to address reported possible drug shortages of products in the Platelet Aggregation Inhibitors drug class. The change allows providers to prescribe these drugs without requiring a non-preferred prior authorization and people enrolled in Medicaid continued access to necessary medication. A list of the affected drugs is below. This is a temporary change until the preferred products are sufficiently available in the market.

Contact vdp-formulary@hhsc.state.tx.us with questions or for more information.

NDC  Label Name
43598033960 ASPIRIN-DIPYRIDAM ER 25-200 MG
49884000702 ASPIRIN-DIPYRIDAM ER 25-200 MG
62559085060 ASPIRIN-DIPYRIDAM ER 25-200 MG
65162059606 ASPIRIN-DIPYRIDAM ER 25-200 MG
70436009205 ASPIRIN-DIPYRIDAM ER 25-200 MG
68462040560 ASPIRIN-DIPYRIDAM ER 25-200 MG

 

Tags: 
PDL